Impedimed Ltd (IPD)

Currency in AUD
0.045
-0.002(-4.26%)
Closed·
IPD Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
IPD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0450.047
52 wk Range
0.0260.068
Key Statistics
Bid/Ask
0.045 / 0.047
Prev. Close
0.045
Open
0.047
Day's Range
0.045-0.047
52 wk Range
0.026-0.068
Volume
1.33M
Average Volume (3m)
2.64M
1-Year Change
-20.34%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IPD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.146
Upside
+224.84%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Impedimed Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Impedimed Ltd Company Profile

ImpediMed Limited, a medical technology company, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices in the Unites States and Europe. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema and deliver snapshot of fluid status and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-car body composition analysis; and HF-Dex analysis for point-or care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company was incorporated in 1999 and is headquartered in Carlsbad, California with additional office in Lindfield, Australia.

Compare IPD to Peers and Sector

Metrics to compare
IPD
Peers
Sector
Relationship
P/E Ratio
−4.5x−3.5x−0.5x
PEG Ratio
0.00−0.170.00
Price/Book
3.0x4.2x2.6x
Price / LTM Sales
8.3x3.4x3.3x
Upside (Analyst Target)
218.8%42.0%42.8%
Fair Value Upside
Unlock7.5%6.5%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.146
(+224.84% Upside)

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / 4.80M
EPS Revisions
Last 90 days

IPD Income Statement

FAQ

What Stock Exchange Does Impedimed Trade On?

Impedimed is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Impedimed?

The stock symbol for Impedimed is "IPD."

What Is the Impedimed Market Cap?

As of today, Impedimed market cap is 91.29M.

What Is Impedimed's Earnings Per Share (TTM)?

The Impedimed EPS (TTM) is -0.01.

When Is the Next Impedimed Earnings Date?

Impedimed will release its next earnings report on 22 Oct 2025.

From a Technical Analysis Perspective, Is IPD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Impedimed Stock Split?

Impedimed has split 6 times.

How Many Employees Does Impedimed Have?

Impedimed has 83 employees.

What is the current trading status of Impedimed (IPD)?

As of 06 Aug 2025, Impedimed (IPD) is trading at a price of 0.05, with a previous close of 0.05. The stock has fluctuated within a day range of 0.05 to 0.05, while its 52-week range spans from 0.03 to 0.07.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.